# Colchicine for the Prevention of Recurrence in Cerebral Amyloid Angiopathy RElated IntraCerebral Hemorrhage

> **NCT07026994** · PHASE2 · RECRUITING · sponsor: **Huashan Hospital** · enrollment: 80 (estimated)

## Conditions studied

- Cerebral Amyloid Angiopathy
- Intracerebral Hemorrhage Lobar

## Interventions

- **DRUG:** Colchicine 0.5mg
- **DRUG:** Matching placebo

## Key facts

- **NCT ID:** NCT07026994
- **Lead sponsor:** Huashan Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-18
- **Primary completion:** 2027-12
- **Final completion:** 2027-12
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2025-06-26

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07026994

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07026994, "Colchicine for the Prevention of Recurrence in Cerebral Amyloid Angiopathy RElated IntraCerebral Hemorrhage". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT07026994. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*